Table 4.
Ref.
|
Epidemiological figures
|
Latest research
|
Type or etiology of cirrhosis
|
Reported data
|
Prevalence | ||||
[6] | Age-standardized prevalence | GBD 2017 | Cirrhosis | Compensated cirrhosis: 1395.0 (1323.5-1470.5); decompensated cirrhosis: 132.5 (128.6-136.2) per 100000 |
[6] | Age-standardized prevalence | GBD 2017 | HBV-related cirrhosis | Compensated cirrhosis: 451.9 (420.0-485.9); decompensated cirrhosis: 36.6 (34.7-38.4) |
[6] | Age-standardized prevalence | GBD 2017 | HCV-related cirrhosis | Compensated cirrhosis: 341.1 (314.1-368.7); decompensated cirrhosis: 32.5 (30.6-34.5) |
[6] | Age-standardized prevalence | GBD 2017 | Alcohol-related cirrhosis | Compensated cirrhosis: 288.1 (267.5-311.3); decompensated cirrhosis: 30.0 (28.2-31.8) |
[6] | Age-standardized prevalence | GBD 2017 | NASH-related cirrhosis | Compensated cirrhosis: 115.5 (105.0-126.5); decompensated cirrhosis: 11.3 (10.4-12.1) |
Incidence | ||||
[24] | Age-standardized incidence | GBD 2017 | NASH-related cirrhosis | 4.81 (4.38-5.28) |
[26] | Age-standardized incidence | GBD 2019 | HBV-related cirrhosis | 4.91 (3.50-6.50) |
[26] | Age-standardized incidence | GBD 2019 | HCV-related cirrhosis | 6.7 (5.0-8.6) |
Mortality | ||||
[26] | Age-standardized Mortality | GBD 2019 | HBV-related cirrhosis | 4.03 (3.39-4.76) |
[26] | Age-standardized Mortality | GBD 2019 | HCV-related cirrhosis | 4.82 (4.09-5.57) |
[25] | Age-standardized mortality | GBD 2017 | NASH-related cirrhosis | 1.5 (1.3-1.6) |
Public health burden | ||||
[52] | DALYs | GBD 2019 | HBV-related cirrhosis | 129.8 (95%CI 108.3-153.0) |
[52] | DALYs | GBD 2019 | HCV-related cirrhosis | 146.2 (124.4-169.8) |
GBD: Global burden of diseases, injuries, and risk factors study; HBV: Hepatitis B virus; HCV: Hepatitis C virus; UI: Uncertainty interval; CI: Confidence interval; NASH: Nonalcoholic steatohepatitis; DALYs: Disability-adjusted life-years.